Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.930
+0.035 (1.85%)
At close: Sep 22, 2026, 4:00 PM EDT
1.960
+0.030 (1.55%)
Pre-market: Sep 23, 2026, 7:48 AM EDT
Equillium Market Cap
Equillium has a market cap or net worth of $122.38 million as of September 22, 2026. Its market cap has increased by 40.87% in one year.
Market Cap
122.38M
Enterprise Value
65.80M
1-Year Change
40.87%
Ranking
Category
Stock Price
$1.93
ChartMarket Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $122.38M, a decrease of -47.82%. That is a compound annual growth rate of -7.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 122.38M | 29.66% |
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biomea Fusion | 125.40M |
| OnKure Therapeutics | 123.92M |
| Nautilus Biotechnology | 122.76M |
| ProMIS Neurosciences | 122.23M |
| Aardvark Therapeutics | 121.90M |
| Cibus | 119.23M |
| Coya Therapeutics | 116.35M |
| Rani Therapeutics Holdings | 115.98M |